Form D · Other
XORTX Therapeutics Inc.
Calgary, A0 · CIK 0001729214
Offering snapshot reported Oct 31, 2024 · SEC filing
- Reported sold
- $0 Offering amount: $1.77M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 18, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 31, 2024 | Initial | $0 | No comparison | 1 | SEC filing |
| Jan 25, 2018 | Initial | $505,283 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $105K
- Finders' fees
- $0
- Form D file number
- 021-528293
The $1,767,566 may be received upon the exercise of share purchase warrants sold inside and outside the U.S.
One warrant entitles the holder thereof to purchase one common share of the Company at an exercise price of US$2.18 per share for a period of five years following the issuance of the warrants.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| A.G.P./Alliance Global Partners | 8361 |
Source: Form D, filed Oct 31, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Allen Davidoff | Director, Executive |
| Stacy Evans | Executive |
| James Fairbairn | Executive |
| William Farley | Director |
| Anthony J. Giovinazzo | Director |
| Stephen Haworth | Executive |
| Abigail Jenkins | Director |
| John Meekison | Executive |
| Alan Moore | Director |
| Raymond Pratt | Director |
| Bruce Rowlands | Director |
| Patrick Treanor | Director |
| Paul Van Damme | Director |
Issuer details
Industry: Other (See others in industry)
Address:
3710 33rd Street Nw
Calgary, A0, T2L 2M1
Calgary, A0, T2L 2M1